Cargando…
NRG1 is a critical regulator of differentiation in TP63-driven squamous cell carcinoma
Squamous cell carcinomas (SCCs) account for the majority of cancer mortalities. Although TP63 is an established lineage-survival oncogene in SCCs, therapeutic strategies have not been developed to target TP63 or it’s downstream effectors. In this study we demonstrate that TP63 directly regulates NRG...
Autores principales: | Hegde, Ganapati V, de la Cruz, Cecile, Giltnane, Jennifer M, Crocker, Lisa, Venkatanarayan, Avinashnarayan, Schaefer, Gabriele, Dunlap, Debra, Hoeck, Joerg D, Piskol, Robert, Gnad, Florian, Modrusan, Zora, de Sauvage, Frederic J, Siebel, Christian W, Jackson, Erica L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606022/ https://www.ncbi.nlm.nih.gov/pubmed/31144617 http://dx.doi.org/10.7554/eLife.46551 |
Ejemplares similares
-
TP63 Is Significantly Upregulated in Diabetic Kidney
por: Liang, Sitai, et al.
Publicado: (2021) -
Repression of Wnt/β-catenin response elements by p63 (TP63)
por: Katoh, Iyoko, et al.
Publicado: (2016) -
Antibody-mediated stabilization of NRG1 induces behavioral and electrophysiological alterations in adult mice
por: Dominguez, Sara L., et al.
Publicado: (2018) -
Mosaic TP63 variant and associated ectodermal dysplasia features
por: Chen, Vivien, et al.
Publicado: (2021) -
Tooth defects of EEC and AEC syndrome caused by heterozygous TP63 mutations in three Chinese families and genotype‐phenotype correlation analyses of TP63‐related disorders
por: Zheng, Jinglei, et al.
Publicado: (2019)